LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LSB LakeShore Biopharma Co., Ltd.

Delisted 12-19 16:45:56 EST

0.6270

+0.0000

0.00%

High0.6270	Low0.6270	Vol0.00
Open0.6270	D1 Closing0.6270	Amplitude0.00%
Mkt Cap25.84M	Tradable Cap16.13M	Total Shares41.21M
T/O0.00	T/O Rate0.00%	Tradable Shares25.73M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LSB","market":"US","secType":"STK","nameCN":"LakeShore Biopharma Co., Ltd.","latestPrice":0.627,"timestamp":1766178000000,"preClose":0.627,"halted":4,"volume":0,"delay":0,"floatShares":25732199,"shares":41212693,"eps":-0.71916,"marketStatus":"Delisted","change":0,"latestTime":"12-19 16:45:56 EST","open":0.627,"high":0.627,"low":0.627,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.71916,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766192400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.627,"volumeRatio":0},"requestUrl":"/m/hq/s/LSB","defaultTab":"news","newsList":[{"id":"2588583650","title":"Deutsche Bank Raises Price Target on LSB Industries to $11 From $9, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2588583650","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588583650?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:23","pubTimestamp":1764678191,"startTime":"0","endTime":"0","summary":"LSB Industries (LXU) has an average rating of overweight and mean price target of $10.90, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LSB","DB"],"gpt_icon":0},{"id":"2582803146","title":"LSB Industries Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2582803146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582803146?lang=en_us&edition=fundamental","pubTime":"2025-11-11 00:04","pubTimestamp":1762790640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 11:04 ET (16:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB"],"gpt_icon":0},{"id":"2582879879","title":"RBC Raises Price Target on LSB Industries to $10 From $9, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879879","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879879?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:56","pubTimestamp":1762779396,"startTime":"0","endTime":"0","summary":"LSB Industries (LXU) has an average rating of overweight and mean price target of $10.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LSB"],"gpt_icon":0},{"id":"2579793931","title":"LSB Industries Is Maintained at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2579793931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579793931?lang=en_us&edition=fundamental","pubTime":"2025-10-31 03:33","pubTimestamp":1761852780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 30, 2025 15:33 ET (19:33 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB"],"gpt_icon":0},{"id":"2579212366","title":"UBS Adjusts LSB Industries Price Target to $9.50 From $9.25, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2579212366","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579212366?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:50","pubTimestamp":1761832207,"startTime":"0","endTime":"0","summary":"LSB Industries (LXU) has an average rating of overweight and mean price target of $10.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LSB"],"gpt_icon":0},{"id":"2579139488","title":"LSB Industries reports Q3 EPS 10c, two estimates 14c","url":"https://stock-news.laohu8.com/highlight/detail?id=2579139488","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579139488?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:37","pubTimestamp":1761770270,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $155.4M, consensus $138.3M. “The third quarter presented a strong market backdrop, and we delivered solid results with clear mom...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lsb-industries-reports-q3-eps-10c-two-estimates-14c-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lsb-industries-reports-q3-eps-10c-two-estimates-14c-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB"],"gpt_icon":0},{"id":"2579713307","title":"LSB Industries Q3 EPS $0.10 Beats $0.05 Estimate, Sales $155.431M Beat $133.830M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2579713307","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579713307?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:13","pubTimestamp":1761768794,"startTime":"0","endTime":"0","summary":"LSB Industries (NYSE:LXU) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.05 by 100 percent. This is a 190.91 percent increase over losses of $(0.11) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48511641/lsb-industries-q3-eps-0-10-beats-0-05-estimate-sales-155-431m-beat-133-830m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"LSB Industries Q3 EPS $0.10 Beats $0.05 Estimate, Sales $155.431M Beat $133.830M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB"],"gpt_icon":0},{"id":"2566971573","title":"LakeShore Biopharma Gets Nasdaq Delisting Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2566971573","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566971573?lang=en_us&edition=fundamental","pubTime":"2025-09-12 20:37","pubTimestamp":1757680637,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma  said Friday it received a staff determination letter from the Nasdaq Stock Market indicating an intention to delist its securities from the exchange after it was found to be out of compliance with Nasdaq Listing Rules after the closing bid price for its ordinary shares fell below $1.00 per share for 30 consecutive business days.The company is not eligible for the standard 180-day compliance period since it effected a stock split in the past year.According to LakeShore, unless it requests an appeal, trading in its securities will be suspended on Sept. 22, and further steps will be taken to remove its securities from listing and registration on Nasdaq.The company said it was considering available options.LakeShore Biopharma shares were down 2% in recent premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B64PRP62.GBP",".IXIC","LU2095319765.USD","LU0314104364.USD","IE00B3QW5Z07.USD","NDAQ","LU2210150020.SGD","BK4112","BK4585","NQmain","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4139","LSB","LU2210149790.SGD"],"gpt_icon":0},{"id":"2566979281","title":"LakeShore Biopharma receives delisting notice from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2566979281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566979281?lang=en_us&edition=fundamental","pubTime":"2025-09-12 20:05","pubTimestamp":1757678728,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) announced that it received a staff determination letter from the Nasdaq Stock Market, dated September 11, 2025, notifying...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakeshore-biopharma-receives-delisting-notice-from-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakeshore-biopharma-receives-delisting-notice-from-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","PSQ","IE00BGHQF748.EUR","QID","BK4585",".IXIC","LU2095319765.USD","TQQQ","MNQmain","LU2210150020.SGD","TSYW.SI","IE00BKPKM429.USD","BK4139","LU0314104364.USD","USJW.SI","QLD","NVIW.SI","NQmain","LSB","BK4112","SQQQ","BK4588","NDAQ","IE00B3QW5Z07.USD","USAW.SI"],"gpt_icon":0},{"id":"2560907299","title":"LakeShore Biopharma Gets Buyout Bid From Oceanpine Capital; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2560907299","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560907299?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:32","pubTimestamp":1755520329,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) shares were up nearly 8% in recent Monday premarket activity after the company said it had received a preliminary non-binding proposal letter from Oceanpine Capital to acquir","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2556087858","title":"Press Release: LakeShore Biopharma Announces Fiscal Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2556087858","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556087858?lang=en_us&edition=fundamental","pubTime":"2025-08-01 02:55","pubTimestamp":1753988100,"startTime":"0","endTime":"0","summary":"-- Total revenue reached RMB615.0 million, representing 7.2% year-over-year. -- Gross profit rose to RMB507.2 million, up 11.3% year-over-year. -- Gross margin improved to 82.5% from 79.5% in Fiscal Year 2024. -- Total operating expenses decreased 34.2% year-over-year to RMB593.5. \"We are pleased to announce LakeShore Biopharma's FY2025 financial results with a 7.2% year-over-year growth in revenues and an 11.3% year-over-year growth in gross profits. Our net loss narrowed by 77% year-over-year\", stated Xu Wang, Director and Chief Executive Officer. \"While we didn't meet the revenue guidance of RMB665-700 million and our adjusted EBITDA guidance range of RMB76-89 million, we have achieved significantly improved results compared to last year, despite substantial challenges. These include intensified competition in the rabies vaccine industry market, particularly in the second half of Fiscal Year 2025, pricing pressures in certain regions, limited capacity of major vaccine distribution c","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","BK4099","LSB","BK4555","R","BK4585","BK4022","03160","BK4604","TM","BK4588"],"gpt_icon":0},{"id":"2555026903","title":"LSB Industries Down Over 11%, on Pace for Largest Percent Decrease Since November 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2555026903","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555026903?lang=en_us&edition=fundamental","pubTime":"2025-07-31 00:38","pubTimestamp":1753893480,"startTime":"0","endTime":"0","summary":"LSB Industries, Inc.  is currently at $7.74, down $0.98 or 11.19%. --Would be lowest close since June 26, 2025, when it closed at $7.64. --On pace for largest percent decrease since Nov. 7, 2022, when it fell 13.8%. --Down 0.83% month-to-date; on pace for worst month since April 2025, when it fell 3.19%. --Down 79.02% from its all-time closing high of $36.88 on May 27, 2011. --Down 15.09% from 52 weeks ago , when it closed at $9.11. --Up 55.32% from its 52-week closing low of $4.98 on April 21, 2025. --Traded as low as $7.09; lowest intraday level since May 22, 2025, when it hit $7.02. --Down 18.6% at today's intraday low; largest intraday percent decrease since Aug. 18, 2020, when it fell as much as 28.38%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4098","BK4139","LSB","LXU"],"gpt_icon":0},{"id":"2555693440","title":"LSB Industries Q2 EPS $0.04 Misses $0.19 Estimate, Sales $151.296M Miss $153.810M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2555693440","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555693440?lang=en_us&edition=fundamental","pubTime":"2025-07-30 04:11","pubTimestamp":1753819904,"startTime":"0","endTime":"0","summary":"LSB Industries (NYSE:LXU) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.19 by 78.95 percent. This is a 69.23 percent decrease over earnings of $0.13 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/07/46705179/lsb-industries-q2-eps-0-04-misses-0-19-estimate-sales-151-296m-miss-153-810m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2553524263","title":"LSB Industries Cut to Neutral From Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2553524263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553524263?lang=en_us&edition=fundamental","pubTime":"2025-07-24 00:47","pubTimestamp":1753289220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 23, 2025 12:47 ET (16:47 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXU","LSB"],"gpt_icon":0},{"id":"2553217237","title":"UBS Downgrades LSB Industries to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2553217237","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553217237?lang=en_us&edition=fundamental","pubTime":"2025-07-23 19:39","pubTimestamp":1753270766,"startTime":"0","endTime":"0","summary":"UBS Downgrades LSB Industries to Neutral From Buy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LSB","LXU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lakeshorebio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.3602},{"period":"1year","weight":-0.7444},{"period":"ytd","weight":-0.8188}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.","exchange":"NASDAQ","name":"LakeShore Biopharma Co., Ltd.","nameEN":"LakeShore Biopharma Co., Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LakeShore Biopharma Co., Ltd.(LSB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LakeShore Biopharma Co., Ltd.,LSB,LakeShore Biopharma Co., Ltd.股票,LakeShore Biopharma Co., Ltd.股票老虎,LakeShore Biopharma Co., Ltd.股票老虎国际,LakeShore Biopharma Co., Ltd.行情,LakeShore Biopharma Co., Ltd.股票行情,LakeShore Biopharma Co., Ltd.股价,LakeShore Biopharma Co., Ltd.股市,LakeShore Biopharma Co., Ltd.股票价格,LakeShore Biopharma Co., Ltd.股票交易,LakeShore Biopharma Co., Ltd.股票购买,LakeShore Biopharma Co., Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LakeShore Biopharma Co., Ltd.(LSB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction